These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 18486472

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
    Costa MS, Boechat N, Rangel EA, da Silva Fde C, de Souza AM, Rodrigues CR, Castro HC, Junior IN, Lourenço MC, Wardell SM, Ferreira VF.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8644-53. PubMed ID: 16949290
    [Abstract] [Full Text] [Related]

  • 3. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J, Reeve N, Hobrath JV, Reynolds RC, Calderón AI.
    Tuberculosis (Edinb); 2014 Mar 15; 94(2):152-8. PubMed ID: 24429106
    [Abstract] [Full Text] [Related]

  • 4. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
    Gill C, Jadhav G, Shaikh M, Kale R, Ghawalkar A, Nagargoje D, Shiradkar M.
    Bioorg Med Chem Lett; 2008 Dec 01; 18(23):6244-7. PubMed ID: 18930654
    [Abstract] [Full Text] [Related]

  • 5. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M, Verma S, Sharma S, Srinivasan A, Singh TP, Kaur P.
    Chem Biol Drug Des; 2010 Sep 01; 76(3):277-84. PubMed ID: 20626408
    [Abstract] [Full Text] [Related]

  • 6. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C, Chollet A, Rodriguez F, Inard C, Pasca MR, Lherbet C, Baltas M.
    Eur J Med Chem; 2012 Jun 01; 52():275-83. PubMed ID: 22483635
    [Abstract] [Full Text] [Related]

  • 7. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI.
    J Chem Inf Model; 2009 Jan 01; 49(1):35-42. PubMed ID: 19063713
    [Abstract] [Full Text] [Related]

  • 8. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J, Waisser K, Kunes J, Kaustová J.
    Arch Pharm (Weinheim); 2005 Aug 01; 338(8):385-9. PubMed ID: 16041837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Vanheusden V, Munier-Lehmann H, Froeyen M, Busson R, Rozenski J, Herdewijn P, Van Calenbergh S.
    J Med Chem; 2004 Dec 02; 47(25):6187-94. PubMed ID: 15566289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
    Aparna V, Jeevan J, Ravi M, Desiraju GR, Gopalakrishnan B.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):1014-20. PubMed ID: 16290929
    [Abstract] [Full Text] [Related]

  • 14. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, Santos DS, de Azevedo WF.
    Acta Crystallogr D Biol Crystallogr; 2004 Dec 15; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [Abstract] [Full Text] [Related]

  • 15. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
    Shanmugavelan P, Nagarajan S, Sathishkumar M, Ponnuswamy A, Yogeeswari P, Sriram D.
    Bioorg Med Chem Lett; 2011 Dec 15; 21(24):7273-6. PubMed ID: 22061642
    [Abstract] [Full Text] [Related]

  • 16. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):233-6. PubMed ID: 24314670
    [Abstract] [Full Text] [Related]

  • 17. Interaction of shikimic acid with shikimate kinase.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, de Azevedo WF, Santos DS.
    Biochem Biophys Res Commun; 2004 Dec 03; 325(1):10-7. PubMed ID: 15522194
    [Abstract] [Full Text] [Related]

  • 18. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS, Mehra R, Kumar S, Nargotra A, Singh PP, Khan IA.
    Appl Microbiol Biotechnol; 2016 Jun 03; 100(12):5415-26. PubMed ID: 26887318
    [Abstract] [Full Text] [Related]

  • 19. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K, Sharma M, Trivedi P, Chaturvedi V, Chauhan PM.
    Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4166-70. PubMed ID: 25127167
    [Abstract] [Full Text] [Related]

  • 20. Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosis.
    Manetti F, Magnani M, Castagnolo D, Passalacqua L, Botta M, Corelli F, Saddi M, Deidda D, De Logu A.
    ChemMedChem; 2006 Sep 01; 1(9):973-89. PubMed ID: 16892466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.